• Holder: State Street
• Stake: 0 → 5% (about $12M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 10 · Schedule 13G
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
• Holder: State Street
• Stake: 0 → 5% (about $12M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 10 · Schedule 13G
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
https://www.stocktitan.net/news/VNDA/nereustm-the-goat-of-biscayne-bay-arrives-for-miami-art-zkk1rr3lsc0o.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VNDA/nereustm-the-goat-of-biscayne-bay-arrives-for-miami-art-zkk1rr3lsc0o.html?utm_source=stocktitan-bluesky&utm_medium=social
Hub: https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
Newsletter: https://merlintrader.beehiiv.com/p/week-ahead-10-catalysts-we-re-watching-november-9-13
Hub: https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
Newsletter: https://merlintrader.beehiiv.com/p/week-ahead-10-catalysts-we-re-watching-november-9-13
Duncan Charles Cliff (Insider) bought 10,000 shares at an average price of $3.8094 per common share. (Date: 2026-11-05)
Duncan Charles Cliff (Insider) bought 10,000 shares at an average price of $3.8094 per common share. (Date: 2026-11-05)
• Insider: Charles Cliff Duncan, Director
• Bought: 10,000 shares (about $38K)
• Price: about $3.81 a share · Nov 3-5
• Now Holds: 108,701 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: Charles Cliff Duncan, Director
• Bought: 10,000 shares (about $38K)
• Price: about $3.81 a share · Nov 3-5
• Now Holds: 108,701 shares directly
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
https://www.stocktitan.net/news/VNDA/vanda-pharmaceuticals-announces-participation-at-november-2026-377de2bvg8b4.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VNDA/vanda-pharmaceuticals-announces-participation-at-november-2026-377de2bvg8b4.html?utm_source=stocktitan-bluesky&utm_medium=social
New hub updated: www.merlintrader.com/vanda-pharma...
New hub updated: www.merlintrader.com/vanda-pharma...
New hub updated: www.merlintrader.com/vanda-pharma...
New hub updated: www.merlintrader.com/vanda-pharma...
www.merlintrader.com/vanda-pharma...
www.merlintrader.com/vanda-pharma...
www.merlintrader.com/vanda-pharma...
www.merlintrader.com/vanda-pharma...
Q3 revenue $69.8M, diluted EPS -$0.37.
https://justcharts.merlintrader.com/#VNDA
Not investment advice.
Q3 revenue $69.8M, diluted EPS -$0.37.
https://justcharts.merlintrader.com/#VNDA
Not investment advice.
Q3 revenue $69.8M, diluted EPS -$0.37.
https://justcharts.merlintrader.com/#VNDA
Not investment advice.
Q3 revenue $69.8M, diluted EPS -$0.37.
https://justcharts.merlintrader.com/#VNDA
Not investment advice.
Tue close $3.99, below SMA50 and SMA200, RSI 30.
Hub: https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
Not investment advice.
Chart: https://justcharts.merlintrader.com/#VNDA
Tue close $3.99, below SMA50 and SMA200, RSI 30.
Hub: https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
Not investment advice.
Chart: https://justcharts.merlintrader.com/#VNDA
https://www.stocktitan.net/news/VNDA/vanda-pharmaceuticals-reports-third-quarter-2026-financial-mz2od9cep2iq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VNDA/vanda-pharmaceuticals-reports-third-quarter-2026-financial-mz2od9cep2iq.html?utm_source=stocktitan-bluesky&utm_medium=social
On October 28, 2026, Vanda Pharmaceuticals Inc. issued a press release and is holding a conference call regarding its results of operations and financial condition for the quarter ended September 30, 2026 . The full text of the press release is furnished as Exhibit 99.1 to this Current Re...
On October 28, 2026, Vanda Pharmaceuticals Inc. issued a press release and is holding a conference call regarding its results of operations and financial condition for the quarter ended September 30, 2026 . The full text of the press release is furnished as Exhibit 99.1 to this Current Re...
Information only — not investment advice.
https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
Information only — not investment advice.
https://www.merlintrader.com/vanda-pharmaceuticals-vnda-stock-hub/
https://www.stocktitan.net/news/VNDA/vanda-pharmaceuticals-announces-positive-results-from-study-3601-of-89rgos2ui54k.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VNDA/vanda-pharmaceuticals-announces-positive-results-from-study-3601-of-89rgos2ui54k.html?utm_source=stocktitan-bluesky&utm_medium=social
prismmarketview.com/vanda-report...
prismmarketview.com/vanda-report...
Interactive chart at JC Just Charts: justcharts.merlintrader.com#VNDA
Not investment advice.
Interactive chart at JC Just Charts: justcharts.merlintrader.com#VNDA
Not investment advice.
Фикс доступа к играм: https://bit.ly/k3gup
💬 https://twitch.tv/k3pch00k
🎬 https://youtube.com/@k3pch00k
💰 https://destream.net/live/k3pch00k/donate
😄 https://memealerts.com/k3pch00k
🪩 https://discord.gg/VnDA…
🔗 https://t.me/k3pch00k/3915
Фикс доступа к играм: https://bit.ly/k3gup
💬 https://twitch.tv/k3pch00k
🎬 https://youtube.com/@k3pch00k
💰 https://destream.net/live/k3pch00k/donate
😄 https://memealerts.com/k3pch00k
🪩 https://discord.gg/VnDA…
🔗 https://t.me/k3pch00k/3915